Skip to main content

Main menu

  • Home
  • Current issue
  • Past issues
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Peer reviewer login
  • Journal club
  • Alerts
  • Subscriptions
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

User menu

  • Log in
  • Subscribe
  • Contact Us
  • My Cart

Search

  • Advanced search
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

Login

European Respiratory Society

Advanced Search

  • Home
  • Current issue
  • Past issues
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Peer reviewer login
  • Journal club
  • Alerts
  • Subscriptions

Targeted therapies for lung cancer: how did the game begin?

Nikolaos I. Kanellakis, Tiago Jacinto, Ioannis Psallidas
Breathe 2016 12: 177-179; DOI: 10.1183/20734735.006316
Nikolaos I. Kanellakis
1Oxford Centre for Respiratory Medicine and Oxford Respiratory Trials Unit, Oxford University Hospitals NHS Foundation Trust, Oxford, UK
2Respiratory Medicine Laboratory, Nuffield Dept of Medicine, University Of Oxford, Old Road Campus, Oxford, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Tiago Jacinto
3Instituto and Hospital CUF Porto, Porto, Portugal.
4Centre for Research in Health Technologies and Information Systems, Faculty of Medicine, Porto, Portugal
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ioannis Psallidas
1Oxford Centre for Respiratory Medicine and Oxford Respiratory Trials Unit, Oxford University Hospitals NHS Foundation Trust, Oxford, UK
2Respiratory Medicine Laboratory, Nuffield Dept of Medicine, University Of Oxford, Old Road Campus, Oxford, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: ioannis.psallidas@ndm.ox.ac.uk
  • Article
  • Info & Metrics
  • PDF
Loading

Article Information

vol. 12 no. 2 177-179
DOI 
https://doi.org/10.1183/20734735.006316

Published By 
European Respiratory Society
Print ISSN 
1810-6838
Online ISSN 
2073-4735
History 
  • Published online June 3, 2016.

Copyright & Usage 
©ERS 2016 Breathe articles are open access and distributed under the terms of the Creative Commons Attribution Non-Commercial Licence 4.0.

Author Information

  1. Nikolaos I. Kanellakis1,2,
  2. Tiago Jacinto3,4 and
  3. Ioannis Psallidas1,2⇑
  1. 1Oxford Centre for Respiratory Medicine and Oxford Respiratory Trials Unit, Oxford University Hospitals NHS Foundation Trust, Oxford, UK
  2. 2Respiratory Medicine Laboratory, Nuffield Dept of Medicine, University Of Oxford, Old Road Campus, Oxford, UK
  3. 3Instituto and Hospital CUF Porto, Porto, Portugal.
  4. 4Centre for Research in Health Technologies and Information Systems, Faculty of Medicine, Porto, Portugal
  1. E-mail: ioannis.psallidas{at}ndm.ox.ac.uk
View Full Text

Article usage

Article usage: June 2016 to February 2023

AbstractFullPdf
Jun 20161418988
Jul 20161210863
Aug 2016811437
Sep 20161014317
Oct 20166715
Nov 201613015
Dec 20162273
Jan 20171220
Feb 20171305
Mar 20173353
Apr 20174242
May 20171292
Jun 20173256
Jul 20171277
Aug 20172339
Sep 201743111
Oct 20170305
Nov 201703019
Dec 201721704
Jan 201802034
Feb 20183732
Mar 20180435
Apr 20180534
May 20180999
Jun 201801056
Jul 20180957
Aug 201801737
Sep 201801294
Oct 201821324
Nov 201801649
Dec 201801305
Jan 201921196
Feb 201951366
Mar 201927914
Apr 20190307
May 201925512
Jun 20193604
Jul 20190686
Aug 20190286
Sep 20190148
Oct 20191215
Nov 20191293
Dec 20190198
Jan 20201225
Feb 20200215
Mar 20200195
Apr 20200164
May 20201244
Jun 202012616
Jul 20201176
Aug 20201148
Sep 20202194
Oct 202010329
Nov 20201118
Dec 20201206
Jan 202104013
Feb 20210316
Mar 20212344
Apr 20211268
May 20211246
Jun 20211142
Jul 20212813
Aug 2021195
Sep 202131711
Oct 202102829
Nov 202102514
Dec 20210171
Jan 20220188
Feb 20220163
Mar 20222154
Apr 20220208
May 202202010
Jun 20220166
Jul 202212210
Aug 20220134
Sep 202211110
Oct 2022083
Nov 20220159
Dec 202211915
Jan 20230165
Feb 20230126

Altmetrics

PreviousNext
Back to top
Vol 12 Issue 2 Table of Contents
Breathe: 12 (2)
  • Table of Contents
  • Index by author
Email

Thank you for your interest in spreading the word on European Respiratory Society .

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Targeted therapies for lung cancer: how did the game begin?
(Your Name) has sent you a message from European Respiratory Society
(Your Name) thought you would like to see the European Respiratory Society web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Print
Citation Tools
Targeted therapies for lung cancer: how did the game begin?
Nikolaos I. Kanellakis, Tiago Jacinto, Ioannis Psallidas
Breathe Jun 2016, 12 (2) 177-179; DOI: 10.1183/20734735.006316

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Targeted therapies for lung cancer: how did the game begin?
Nikolaos I. Kanellakis, Tiago Jacinto, Ioannis Psallidas
Breathe Jun 2016, 12 (2) 177-179; DOI: 10.1183/20734735.006316
Reddit logo Technorati logo Twitter logo Connotea logo Facebook logo Mendeley logo
Full Text (PDF)

Jump To

  • Article
    • Abstract
    • EGFR
    • KRAS
    • EML4–ALK
    • Summary
    • Footnotes
    • References
  • Info & Metrics
  • PDF

Subjects

  • Lung cancer
  • Tweet Widget
  • Facebook Like
  • Google Plus One

More in this TOC Section

Expert opinion

  • Lung cancer screening by volume CT
  • In pursuit of the primary
  • A rare complication in a case of nonsmall cell lung carcinoma
Show more Expert opinion

Landmark papers in respiratory medicine

  • Balloon pulmonary angioplasty: lessons learned and unanswered questions
  • A look back at the PANTHER-IPF trial
  • Impact of the meta-analysis of pulmonary rehabilitation by Lacasse et al.
Show more Landmark papers in respiratory medicine

Related Articles

Navigate

  • Home
  • Current issue
  • Archive

About Breathe

  • Journal information
  • Editorial board
  • Press
  • Permissions and reprints
  • Advertising

The European Respiratory Society

  • Society home
  • myERS
  • Privacy policy
  • Accessibility

ERS publications

  • European Respiratory Journal
  • ERJ Open Research
  • European Respiratory Review
  • Breathe
  • ERS books online
  • ERS Bookshop

Help

  • Feedback

For authors

  • Intructions for authors
  • Publication ethics and malpractice
  • Submit a manuscript

For readers

  • Alerts
  • Subjects
  • RSS

Subscriptions

  • Accessing the ERS publications

Contact us

European Respiratory Society
442 Glossop Road
Sheffield S10 2PX
United Kingdom
Tel: +44 114 2672860
Email: journals@ersnet.org

ISSN

Print ISSN: 1810-6838
Online ISSN: 2073-4735

Copyright © 2023 by the European Respiratory Society